PI*SZ individuals generally develop respiratory symptoms at a later age than individuals with more severe AATD (i.e. PI*ZZ, PI*Z null and PI*null null individuals), potentially reflecting the higher average AAT concentrations in PI*SZ individuals [26, 46] and hence a slower disease evolution. Here, SERPINA1 is linked to alpha 1-antitrypsin deficiency.